Ahmed Elserafy
My research focus on developing a regenerative solution as an Advanced Therapy Medicinal Product, for burn victims and chronic wound patients. The ultimate goal is to construct a multilayer construct, based on autologous somatic and/or stem cells.
Research
From lab to patient – Ahmed Elserafy's research heals skin with stem cells
Observing how research can significantly impact people, particularly those affected by conditions like burns, inspires Ahmed Elserafy in his work. Discover more about his involvement in the video.
The Research and Development Unit for Skin and Cultured Cells
Vision
Autologous keratinocytes and stem cells can be expanded, differentiated and combined with other types of cells and/or biomaterials to create variable options for skin regeneration.Mission
Simple and safe skin regenerative solution for burn victims and chronic wound patients.Research strategy
The unit has two research directions for skin regeneration. The first direction is based on isolating the patient’s keratinocytes and applying them to the wound area, with or without pre-expansion in culture. The current research in this direction involves optimizing the laboratory procedure towards the European Directives controlling the advanced therapeutic medicinal products (ATMP). The second direction is based on stem cell differentiation into epidermal cells. Several ongoing studies are investigating different strategies to enhance the differentiation. For both types of cells, a multilayer skin construct established, with or without biomaterials, will serve as a possible clinical solution for large skin defects. Currently, we are finalizing our application for our first clinical trial, using autologous cultured keratinocytes for severe burn victims.Our projects are funded by Region Östergötland and ATMP Sweden.
News
Publications
2025
The Dutch burn care protocol − Reflections on data from the Dutch Burn Registry
Burns Open, Vol. 12, Article 100423
(Article in journal)
https://dx.doi.org/10.1016/j.burnso.2025.100423
Sepsis in burns: lessons learned, challenges remain
MILITARY MEDICAL RESEARCH, Vol. 12, Article 86
(Article in journal)
https://dx.doi.org/10.1186/s40779-025-00677-1
Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan
Clinical and Translational Science, Vol. 18, Article e70433
(Article in journal)
https://dx.doi.org/10.1111/cts.70433
Role of GDH and PARP inhibitors as novel treatments for SDHB-deficient PPGLs
Endocrine-Related Cancer, Vol. 32, Article e250173
(Article in journal)
https://dx.doi.org/10.1530/ERC-25-0173
Rab7 inhibitor enhances stem cell differentiation into keratinocyte-like cells with anti-inflammatory properties
Frontiers in Immunology, Vol. 16, Article 1503007
(Article in journal)
https://dx.doi.org/10.3389/fimmu.2025.1503007